URGENT – Funding opportunities for dementia-related research from the National Institute of Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS)

To all CCNA members,


We wanted to remind you that the NIA and the NINDS are regularly releasing a number of funding opportunities on different areas of research on Alzheimer’s disease and related dementias. Many of these opportunities are open to Canadian researchers and may dovetail nicely with the work you are doing within CCNA.


We have compiled a list of 37 grant opportunities (including 25 calls for RO1 grants), targeted specifically to our fields of research, that are currently available at NIH through the NIA and NINDS agencies. All of the grant calls we are sending you are open to Canadian researchers and institutions. Please note that one of the requirements for foreign researchers applying for grants in the U.S. is the following:


“Proposed research should provide special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions in other countries that are not readily available in the U.S. or that augment existing U.S. resources” (from the National Institute of Health website).


This should not be seen as a deterrent. CCNA researchers have access to the growing database populated by the COMPASS-ND study, providing unprecedented research opportunities on neurodegeneration in aging with a big data perspective and enabling the formulation of unique research questions that cannot be answered with more standard research paradigms.


There are many opportunities for CCNA researchers to leverage their ongoing work and add to the funding they are receiving through the consortium. We strongly encourage all of you to explore these opportunities carefully (please click on the link at the bottom of this page for the list of NIH grants we compiled for you), and to work both within and across teams to develop excellent proposals with high impact.


The next application deadlines for these opportunities are:

  • October 5, 2017 for R01 opportunities; and
  • October 16, 2017 for R03, R21, and R33 opportunities.


The following deadlines are February 5 & 16, 2018, and June 5 & 16, 2018.


We hope that many of you will take advantage of these unprecedented opportunities!


Yours truly,

Howard Chertkow, MD, FRCPC, FCAHS
Scientific Director, CCNA